CYB5R1 drives stemness and malignant progression via STAM2/STAT3 in chemotherapy-enriched triple-negative…

Acquired TRAIL Resistance Promotes Cancer Stemness and Malignant Behavior through CD44-SPHK1-STAT3 Signaling in Colorectal Cancer
Se Lim Kim, Byung Chul Jin, Seung Young Seo +1
Biomolecules & Therapeutics1 Nov 2026Peer-reviewedCC BY-NC 4.0Full textOncologyPMC
Single-Cell Dissection of Inflammatory Suppression and Stemness Plasticity Reveals STMN1-Associated Malignant Epithelial Cells in Severe Lung Cancer.
Yanmei Chen, Sisi Chen, Biao Cheng +3
Chemical biology & drug design1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
FBXO17 regulates the malignant progression of colorectal cancer via the Wnt/β-catenin pathway
Enyan Tang, Yijie Xiao, Xiaohong Qian +2
Translational cancer research28 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
From inflammation to carcinogenesis: MiRNA regulates epithelial-mesenchymal transition to facilitate malignant progression of gastric precancerous lesions
Yibing Tian, Tai Zhang, Bochao Yuan +3
Frontiers in oncology16 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy.
Daniel H Ryan, Yuuki Ohara, Michael J Kruhlak +4
Cancer medicine1 Oct 2026Peer-reviewedCC BY-NCFull textOncologyEurope PMC

Cite

BibTeX

@article{wang2026cyb5r1,
  title = {{CYB5R1 drives stemness and malignant progression via STAM2/STAT3 in chemotherapy-enriched triple-negative breast cancer}},
  author = {Zhongyu Wang and Jia Li and Lin Geng and Yu Zhao and Ke Ma and Xi Ma and Yuanxing Dong and Yi Lu and Jing Liu and Zeren Gasong and Mengjin Yuan and Yang Yu and Wei Luo and Xianhui Ruan},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-75153-4},
  url = {https://www.nature.com/articles/s41598-026-75153-4},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - CYB5R1 drives stemness and malignant progression via STAM2/STAT3 in chemotherapy-enriched triple-negative breast cancer
AU  - Zhongyu Wang
AU  - Jia Li
AU  - Lin Geng
AU  - Yu Zhao
AU  - Ke Ma
AU  - Xi Ma
AU  - Yuanxing Dong
AU  - Yi Lu
AU  - Jing Liu
AU  - Zeren Gasong
AU  - Mengjin Yuan
AU  - Yang Yu
AU  - Wei Luo
AU  - Xianhui Ruan
PY  - 2026
DA  - 2026/10/17
JO  - Scientific Reports
DO  - 10.1038/s41598-026-75153-4
UR  - https://www.nature.com/articles/s41598-026-75153-4
SN  - 2045-2322
ER  -

Related

Cite